Domestic antihyperlipidemic market heats up

With more than 60 items flooding in the local antihyperlipidemic market, a number of domestic pharmaceutical markers listed in the top 10 ranks are taking up a larger proportion of market share even in the face of multinational giants such as Pfizer Korea and MSD Korea, according to a KPMR report released by Bestcare, a local market analysis agency.

The report, which analyzed the sal...